Apolonija Jan
About Apolonija Jan
Apolonija Jan is a Clinical Project Manager at BeiGene in Basel Area, Switzerland, with over 15 years of international experience in clinical trials and a background in marketing and NLP coaching.
Current Role at BeiGene
Apolonija Jan currently holds the position of Clinical Project Manager at BeiGene, based in the Basel Area, Switzerland. She started her tenure at BeiGene in September 2019. Her role involves managing clinical projects, ensuring compliance with protocols, and overseeing project timelines and deliverables.
Previous Experience at Teva Pharmaceuticals
Apolonija Jan has experience working at Teva Pharmaceuticals in two distinct roles. From 2017 to 2018, she served as a Clinical Project Manager. Prior to this, she was employed as a Clinical Trial Manager for Europe and Australia, a role she held from 2015 to 2017. Both positions were based in the Basel Area, Switzerland.
Early Career and Roles
Apolonija Jan's early career includes various roles in clinical research and management. From 2006 to 2007, she worked as a Clinical Research Associate (CRA) at ICON Clinical Research in Budapest, Hungary. She then moved to Argint International, serving as a CRA from 2007 to 2008. Additionally, she worked at Bayer Pharmaceuticals in Slovenia as a CLM, Country Lead Monitor, and Deputy to Local Drug Safety Manager from 2008 to 2011.
Educational Background
Apolonija Jan studied at the University of Ljubljana from 1989 to 1996. Her academic background laid the foundation for her extensive career in clinical research and project management. She also holds certifications as an NLP Practitioner and Life Coach, which augment her capabilities in team leadership and supervision.
Experience in Clinical Trials
With over 15 years of international experience in clinical trials, Apolonija Jan has served in various capacities including Clinical Trial Manager, Local Project Manager, CRA, and Country Lead Monitor. Her expertise spans across phases II to IV studies at both country and site levels. This diverse background equips her with a comprehensive understanding of clinical trial procedures and regulatory requirements.